China

Liang Tao has three decades of clinical experience in cardiovascular surgery. In 2010, he was awarded the "Golden Scalpel Award" by the Chinese Association for Cardiovascular Surgeons. He specializes in a wide range of surgical procedures, including complex congenital heart disease, minimally invasive valve surgery, coronary artery disease, macrovascular disease, cardiac tumours, and heart transplantation. Dr. Tao has also pioneered unique techniques for unicuspid, bicuspid, and tricuspid aortic valve reconstruction, earning widespread acclaim from cardiovascular experts in China and internationally.

Expert Member of the Chinese Medical Association, Vice Chairman of the Heart Rhythm Committee of the Chinese Medical Doctor Association, Executive Member of the Chinese College of Cardiovascular Physicians, Chairman of the Cardiovascular Disease Branch of the Chinese Non-Governmental Medical Institutions Association, Vice Chairman of the Cardiovascular Disease Branch of the China International Exchange and Promotion Association for Medical and Healthcare, Executive Vice Chairman of the Air Rescue Branch of the China Association for Disaster & Emergency Rescue Medicine, Vice Chairman of the Cardiac Rehabilitation Management Committee of the Chinese Hospital Association, Member of the National Cardiovascular Disease Expert Committee.

Dr. Yan graduated from Peking University Health Science Center with a Doctorate in Internal Medicine (Cardiovascular Medicine). She has 29 years of clinical cardiovascular experience, including 19 years of interventional treatment experience in coronary artery disease.

Dr. Yan specialises in the clinical treatment of coronary artery disease, hypertension, heart failure, hyperlipidaemia, and complex/critical cardiovascular conditions. She has particularly in-depth expertise in interventional diagnosis and treatment of coronary artery disease, and has led or participated in over 12,500 complex interventional procedures, including treatment of left main coronary artery disease, arterial calcification, and chronic total occlusions. She is also one of China’s first cardiovascular clinicians to utilize cutting-edge coronary imaging and functional techniques, leveraging tools such as intravascular ultrasound, optical coherence tomography, and fractional flow reserve to diagnose complex coronary lesions, optimize percutaneous coronary interventions, and improve patient outcomes.

Dr. Fu has led and participated in over 7,000 cardiac procedures, including 1,000 macrovascular procedures such as thoracic aortic valve replacement, total aortic arch replacement, and the elephant trunk procedure.

Dr. Chen completed a one-year cardiovascular surgery programme in Japan, as well as observational learning programs at Penn State Health Milton S. Hershey Medical Center and Memorial Hermann Hospital in Houston. He has contributed to a range of national, provincial and municipal scientific research projects, and has published numerous articles in leading Chinese academic journals. 

He currently serves as Expert Advisor to the Wuhan Medical Accident Technical Appraisal Panel, Member of the Chinese Medical Doctor Association Vascular Surgery Committee, Member of the Cardiothoracic Surgery Branch of the Hubei Medical Association, Member of the Cardiothoracic Surgery Committee of the Wuhan Medical Association, and Expert Reviewer for the Hubei Province Clinical Specialty Program.